Bicycle Therapeutics plcBCYCNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank84
5Y CAGR+2.6%
Year-over-Year Change
Year-over-year earnings per share growth rate
5Y CAGR
+2.6%/yr
Long-term compound
Percentile
P84
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 25.44% |
| Q2 2025 | -29.55% |
| Q1 2025 | -18.92% |
| Q4 2024 | 0.00% |
| Q3 2024 | 3.90% |
| Q2 2024 | -24.19% |
| Q1 2024 | 46.55% |
| Q4 2023 | 7.94% |
| Q3 2023 | 10.64% |
| Q2 2023 | -8.46% |
| Q1 2023 | -28.71% |
| Q4 2022 | -5.21% |
| Q3 2022 | -6.67% |
| Q2 2022 | 3.23% |
| Q1 2022 | -47.62% |
| Q4 2021 | -6.78% |
| Q3 2021 | 20.27% |
| Q2 2021 | -1.37% |
| Q1 2021 | 12.05% |
| Q4 2020 | -59.62% |
| Q3 2020 | 22.39% |
| Q2 2020 | -6.35% |
| Q1 2020 | -152.00% |
| Q4 2019 | 52.83% |
| Q3 2019 | 62.14% |
| Q2 2019 | -278.38% |
| Q1 2019 | 26.00% |
| Q4 2018 | 13.79% |
| Q3 2018 | -56.76% |
| Q2 2018 | -94.74% |
| Q1 2018 | 50.00% |
| Q4 2017 | 0.00% |